Update shared on08 Aug 2025
Fair value Decreased 7.69%Despite a notable increase in revenue growth forecasts and a lower projected future P/E, Rayonier Advanced Materials’ consensus analyst price target has been reduced from $6.50 to $6.00.
What's in the News
- Signed MoU with GranBio LLC to explore joint development of a cellulosic Sustainable Aviation Fuel (SAF) facility at the Jesup, Georgia site, leveraging RYAM’s infrastructure and accessing GranBio’s AVAP® technology, partially financed by a $100 million U.S. Department of Energy grant.
- Entered into a new strategic MoU with Verso Energy to evaluate projects at the Jesup site, including CO2 capture and storage, renewable hydrogen production, and e-SAF production using biogenic CO2, with joint feasibility studies underway.
- Shareholders approved amendments to declassify the board of directors and eliminate supermajority voting provisions at the annual general meeting.
Valuation Changes
Summary of Valuation Changes for Rayonier Advanced Materials
- The Consensus Analyst Price Target has fallen from $6.50 to $6.00.
- The Consensus Revenue Growth forecasts for Rayonier Advanced Materials has significantly risen from 0.4% per annum to 2.7% per annum.
- The Future P/E for Rayonier Advanced Materials has significantly fallen from 4.58x to 3.96x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.